Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Income from Continuing Operations (2016 - 2025)

Apyx Medical (APYX) has disclosed Income from Continuing Operations for 15 consecutive years, with 1240000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 105.88% year-over-year to 1240000.0, compared with a TTM value of 11105000.0 through Dec 2025, down 604.09%, and an annual FY2025 reading of 11105000.0, down 604.09% over the prior year.
  • Income from Continuing Operations was 1240000.0 for Q4 2025 at Apyx Medical, up from 1955000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 21103000.0 in Q4 2024 and bottomed at 9624000.0 in Q4 2023.
  • Average Income from Continuing Operations over 5 years is 3311500.0, with a median of 4454500.0 recorded in 2021.
  • Peak annual rise in Income from Continuing Operations hit 319.27% in 2024, while the deepest fall reached 546.32% in 2024.
  • Year by year, Income from Continuing Operations stood at 2010000.0 in 2021, then crashed by 201.74% to 6065000.0 in 2022, then crashed by 58.68% to 9624000.0 in 2023, then surged by 319.27% to 21103000.0 in 2024, then tumbled by 105.88% to 1240000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for APYX at 1240000.0 in Q4 2025, 1955000.0 in Q3 2025, and 3738000.0 in Q2 2025.